Loading
National Health Investors Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 31 May 2024.
National Health Investors Inc: what insiders have been doing
This page follows insider dealings at National Health Investors Inc as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. 16 insiders have disclosed 34 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
No insider has bought National Health Investors Inc shares on the open market in the past twelve months. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade.
For context, the typical company on the same exchange (median of 5,816 companies) published 19 filings over the same period, against 34 filings here. Over the whole record (from 2016), the tally stands at 14 purchases and no sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 375.6 m USD and net income of 142.2 m USD, with a dividend of 3.64 USD per share.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
90
Thresholds
n/a
Buy Volume
€1M
14 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +6.9%Entry US$67.32 · Close at T+365 US$71.98
- +24.7%Entry US$57.47 · Close at T+365 US$71.67
- +54.6%Entry US$51.77 · Close at T+365 US$80.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate National Health Investors Inc Buy (bullish), based on 8 analysts. Average price target: US$80.88.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,576 of 24,148 companies
62.9
score / 100
Value56
Quality70
FCF yld7.3%
Earn yld4.4%
EV/EBITDA16.0x
ROE11%
Gross mgn97%
Net mgn38%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$65.60
Analyst consensus
8 analystsBuy
US$65.00Target US$80.88(+23%)US$90.00
Income statement
RevenueUS$375.6M
Gross profitUS$364.6M97% margin
EBITDAUS$275.7M73% margin
Net incomeUS$142M38.3% margin
Valuation
PER (trailing)19.0x
PER (forward)19.6x
P/Book2.1x
Beta0.52
Balance sheet & cash
Market capUS$3.2B
Total debtUS$1.2B
Free Cash FlowUS$236.6M
Debt / Equity80%
Profitability & ownership
ROE10.7%
ROA4.4%
% insiders2.4%
% institutions79.4%
Last declaration on 17 August 2026
Declarations90 total
33,124 shares@ US$72.500.072% mcap41.8% of flowCommon StockSEC144:0001949846-26-000519
2,370 shares0Common StockSEC:0000877860-26-000182:0
4,726 shares0Common StockSEC:0000877860-26-000088:0
5,072 shares0Common StockSEC:0000877860-26-000086:0
1,268 shares0Common StockSEC:0000877860-26-000084:0
1,268 shares0Common StockSEC:0000877860-26-000078:0
1,268 shares0Shares Of Common StockSEC:0000877860-26-000074:0
2,420 shares0Common StockSEC:0000877860-26-000064:0
1,268 shares0Common StockSEC:0000877860-26-000082:0
1,268 shares0Common StockSEC:0000877860-26-000080:0
1,268 shares0Common StockSEC:0000877860-26-000076:0
5,072 shares0Common StockSEC:0000877860-26-000070:0
4,726 shares0Common StockSEC:0000877860-26-000072:0
14,409 shares0Common StockSEC:0000877860-26-000068:0
3,458 shares0Common StockSEC:0000877860-26-000066:0
8,500 shares@ US$57.768.4% of flowCommon StockSEC:0000877860-26-000037:0
8,333 shares@ US$57.7619.9% of flowCommon StockSEC:0000877860-26-000043:0
8,500 shares@ US$57.7610.8% of flowCommon StockSEC:0000877860-26-000041:0
13,334 shares@ US$57.769.6% of flowCommon StockSEC:0000877860-26-000039:0
10,000 shares@ US$73.3431.5% of flowCommon StockSEC:0000877860-26-000032:0
10,000 shares@ US$73.3418.4% of flowCommon Stock - Jointly held with spouseSEC:0000877860-26-000024:0
25,000 shares@ US$73.3422.9% of flowCommon StockSEC:0000877860-26-000026:0
10,000 shares@ US$73.3418.2% of flowShares Of Common StockSEC:0000877860-26-000022:0
15,000 shares@ US$73.3424.0% of flowCommon StockSEC:0000877860-26-000020:0
2,404 shares@ US$53.415.3% of flowCommon StockSEC:0000877860-26-000018:0
25 of 90 declarations
About National Health Investors Inc
National Health Investors, Inc. (NYSE:NHI) is a U.S.-based healthcare real estate investment trust focused on senior housing and medical real estate. The company was established in 1991 as a Maryland corporation and operates as a self-managed REIT. Its corporate headquarters and operating base are in Murfreesboro, Tennessee, and its property and lending exposure is concentrated entirely in the United States.
NHI’s business model is organized around two reportable segments. The Real Estate Investments segment includes real estate ownership, leases, and mortgage and other notes receivable tied to independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and hospitals. The SHOP segment, or Senior Housing Operating Portfolio, consists of ventures that own and operate independent living and assisted living assets through third-party managers. This structure gives NHI a hybrid profile: part of the portfolio generates contractual triple-net rental income, while the SHOP assets provide more direct exposure to operating performance in senior housing.
Read moreShow less
From a competitive standpoint, NHI is positioned as a specialized healthcare REIT with a long operating history and a diversified multi-state footprint. Its strategy is centered on need-driven and discretionary senior housing as well as select medical facilities, which allows it to serve an aging demographic while balancing asset-level risk. The company funds investments through operating cash flow, debt capital, and equity issuance. As of year-end 2024, NHI reported gross investments of approximately $2.6 billion across 172 healthcare real estate properties in 31 states, primarily leased under triple-net arrangements to 27 tenants, plus a portfolio of 16 mortgages and other notes receivable. Its SHOP platform comprised 15 properties across eight states.
Recent developments indicate an active capital-recycling and growth strategy. In 2025, NHI reported solid operating results and provided 2026 guidance for FFO and FAD that pointed to continued improvement, while keeping leverage within its targeted range. In the first quarter of 2026, the company announced additional portfolio activity, including the acquisition of a nine-property assisted living portfolio for $105.5 million, and disclosed a sizeable investment pipeline that is primarily focused on SHOP assets and senior housing sale-leaseback opportunities. That suggests management is prioritizing private-pay senior housing, disciplined underwriting, and selective expansion.
For French, Belgian, and Swiss investors, NHI is a U.S. NYSE-listed healthcare real estate name with a defensive income profile, but one that remains sensitive to interest rates, operator credit quality, lease renewals, and execution risk across senior housing transitions and acquisitions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
